Press Release

BioLegend® and New York Genome Center® Enter into Exclusive Global License and Research Agreement for CITE-seq™, a Novel Technique for Multidimensional Single Cell Analysis

BioLegend, Inc. (“BioLegend”) and the New York Genome Center (“NYGC”) announced today that they have entered into an exclusive worldwide license and collaborative research agreement for CITE-seq™ technology for use in the research field. CITE-seq™, Cellular Indexing of Transcriptomes and ...

Read More »

Expert view: The future of single-cell sequencing

The power of single-cell sequencing and its application in the field of oncology remains a top opportunity for discoveries that could have a huge impact on improving human health worldwide. However, barriers remain before those studies can be furthered… With ...

Read More »